Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement.read on In 2015, we pioneered a “moneyball for biotech”
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
We are rebuilding biotech for the AI era. When a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual, disconnected
VP, Head of Global Access, Value and Pricing Location: Basel, BS, CH About Idorsia Pharmaceuticals Ltd Headquartered near Basel, Switzerland – a European biotech hub – Idorsia has a highly experienced team of dedicated professionals, covering all
About Us: DeepJudge is Switzerland’s leading AI and ICT scale-up, transforming how law firms and legal departments access and leverage their knowledge. Founded by former Google search engineers with PhDs in AI from ETH Zurich, and
About Us: DeepJudge is Switzerland’s leading AI and ICT scale-up, transforming how law firms and legal departments access and leverage their knowledge. Founded by former Google search engineers with PhDs in AI from ETH Zurich, and
Chief Technology Officer – Robotics, AI & Digital Transformation InnoFuture GmbH Vacant since: Number of jobs: 1 8953 Dietikon (ZH) 100% By agreement Permanent Position Summary The Chief Technology Officer will be responsible for the companys
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Your responsibilities : Fair marketing & brand experience Serve as the global owner of fair marketing and experiential initiatives, shaping frameworks, prioritisation, final sign-off for integrated campaigns across all Art Basel shows with clear cultural brand